PDS Intangible Assets vs Long Term Debt Total Analysis

Stocks . USA . 
Stock . PDS Biotechnology Corp
PDSB Stock  USD 1.26  0.01  0.80%   
PDS Biotechnology financial indicator trend analysis is much more than just breaking down PDS Biotechnology Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether PDS Biotechnology Corp is a good investment. Please check the relationship between PDS Biotechnology Intangible Assets and its Long Term Debt Total accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PDS Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Intangible Assets vs Long Term Debt Total

JavaScript chart by amCharts 3.21.152016201820202022202438K39K40K41K42K43K44K45K46K47K48K49K50K51K 4M6M8M10M12M14M16M18M20M22M24M
JavaScript chart by amCharts 3.21.15Intangible Assetstotal: 527.7KLong Term Debt Totaltotal: 219M

Intangible Assets vs Long Term Debt Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of PDS Biotechnology Corp Intangible Assets account and Long Term Debt Total. At this time, the significance of the direction appears to have pay attention.
Intangible AssetsLong Term Debt TotalDiversified AwayIntangible AssetsLong Term Debt TotalDiversified Away100%
The correlation between PDS Biotechnology's Intangible Assets and Long Term Debt Total is -0.89. Overlapping area represents the amount of variation of Intangible Assets that can explain the historical movement of Long Term Debt Total in the same time period over historical financial statements of PDS Biotechnology Corp, assuming nothing else is changed. The correlation between historical values of PDS Biotechnology's Intangible Assets and Long Term Debt Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Intangible Assets of PDS Biotechnology Corp are associated (or correlated) with its Long Term Debt Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt Total has no effect on the direction of Intangible Assets i.e., PDS Biotechnology's Intangible Assets and Long Term Debt Total go up and down completely randomly.

Correlation Coefficient

-0.89
Relationship DirectionNegative 
Relationship StrengthSignificant

Intangible Assets

Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.

Long Term Debt Total

Most indicators from PDS Biotechnology's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into PDS Biotechnology Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PDS Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
At present, PDS Biotechnology's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 19.3 M, whereas Tax Provision is forecasted to decline to (1.3 M).
 2022 2023 2024 2025 (projected)
Interest Expense1.3M4.2M4.7B4.9B
Depreciation And Amortization49.1K57.3K65.9K62.6K

PDS Biotechnology fundamental ratios Correlations

Total Assets
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Net Receivables
Common Stock Total Equity
Common Stock Shares Outstanding
Non Current Liabilities Total
Other Current Assets
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Total Current Assets
Common Stock
Short Long Term Debt Total
Current Deferred Revenue
Short Term Debt
Other Assets
Total Assets
1.01.01.01.0-1.0-1.01.01.01.0-0.361.0-0.220.260.671.01.01.01.0-0.171.01.01.00.951.0-0.2
Other Current Liab
1.01.01.01.0-1.0-1.01.01.01.0-0.361.0-0.220.260.671.01.01.01.0-0.171.01.01.00.951.0-0.2
Total Current Liabilities
1.01.01.01.0-1.0-1.01.01.01.0-0.361.0-0.220.260.671.01.01.01.0-0.171.01.01.00.951.0-0.2
Total Stockholder Equity
1.01.01.01.0-1.0-1.01.01.01.0-0.361.0-0.230.270.671.01.01.01.0-0.171.01.01.00.951.0-0.2
Property Plant And Equipment Net
1.01.01.01.0-1.0-1.01.01.01.0-0.351.0-0.230.270.671.01.01.01.0-0.161.01.01.00.951.0-0.2
Net Debt
-1.0-1.0-1.0-1.0-1.01.0-1.0-1.0-1.00.36-1.00.23-0.27-0.67-1.0-1.0-1.0-1.00.17-1.0-1.0-1.0-0.96-1.00.2
Retained Earnings
-1.0-1.0-1.0-1.0-1.01.0-1.0-1.0-1.00.36-1.00.22-0.27-0.67-1.0-1.0-1.0-1.00.17-1.0-1.0-1.0-0.96-1.00.2
Accounts Payable
1.01.01.01.01.0-1.0-1.01.01.0-0.361.0-0.220.260.671.01.01.01.0-0.171.01.01.00.951.0-0.2
Cash
1.01.01.01.01.0-1.0-1.01.01.0-0.361.0-0.230.260.671.01.01.01.0-0.171.01.01.00.951.0-0.2
Non Current Assets Total
1.01.01.01.01.0-1.0-1.01.01.0-0.351.0-0.230.270.671.01.01.01.0-0.161.01.01.00.951.0-0.2
Non Currrent Assets Other
-0.36-0.36-0.36-0.36-0.350.360.36-0.36-0.36-0.35-0.360.09-0.12-0.72-0.36-0.36-0.36-0.360.58-0.36-0.36-0.36-0.34-0.36-0.31
Cash And Short Term Investments
1.01.01.01.01.0-1.0-1.01.01.01.0-0.36-0.230.260.671.01.01.01.0-0.171.01.01.00.951.0-0.2
Net Receivables
-0.22-0.22-0.22-0.23-0.230.230.22-0.22-0.23-0.230.09-0.23-0.75-0.46-0.22-0.22-0.22-0.22-0.38-0.22-0.22-0.22-0.21-0.22-0.12
Common Stock Total Equity
0.260.260.260.270.27-0.27-0.270.260.260.27-0.120.26-0.750.520.260.260.260.260.410.260.260.260.30.26-0.27
Common Stock Shares Outstanding
0.670.670.670.670.67-0.67-0.670.670.670.67-0.720.67-0.460.520.670.670.670.67-0.320.670.670.670.640.67-0.13
Non Current Liabilities Total
1.01.01.01.01.0-1.0-1.01.01.01.0-0.361.0-0.220.260.671.01.01.0-0.171.01.01.00.951.0-0.2
Other Current Assets
1.01.01.01.01.0-1.0-1.01.01.01.0-0.361.0-0.220.260.671.01.01.0-0.171.01.01.00.951.0-0.2
Other Stockholder Equity
1.01.01.01.01.0-1.0-1.01.01.01.0-0.361.0-0.220.260.671.01.01.0-0.171.01.01.00.951.0-0.2
Total Liab
1.01.01.01.01.0-1.0-1.01.01.01.0-0.361.0-0.220.260.671.01.01.0-0.171.01.01.00.951.0-0.2
Property Plant And Equipment Gross
-0.17-0.17-0.17-0.17-0.160.170.17-0.17-0.17-0.160.58-0.17-0.380.41-0.32-0.17-0.17-0.17-0.17-0.17-0.17-0.17-0.16-0.17-0.21
Total Current Assets
1.01.01.01.01.0-1.0-1.01.01.01.0-0.361.0-0.220.260.671.01.01.01.0-0.171.01.00.951.0-0.2
Common Stock
1.01.01.01.01.0-1.0-1.01.01.01.0-0.361.0-0.220.260.671.01.01.01.0-0.171.01.00.951.0-0.2
Short Long Term Debt Total
1.01.01.01.01.0-1.0-1.01.01.01.0-0.361.0-0.220.260.671.01.01.01.0-0.171.01.00.951.0-0.2
Current Deferred Revenue
0.950.950.950.950.95-0.96-0.960.950.950.95-0.340.95-0.210.30.640.950.950.950.95-0.160.950.950.950.95-0.19
Short Term Debt
1.01.01.01.01.0-1.0-1.01.01.01.0-0.361.0-0.220.260.671.01.01.01.0-0.171.01.01.00.95-0.2
Other Assets
-0.2-0.2-0.2-0.2-0.20.20.2-0.2-0.2-0.2-0.31-0.2-0.12-0.27-0.13-0.2-0.2-0.2-0.2-0.21-0.2-0.2-0.2-0.19-0.2
Click cells to compare fundamentals

PDS Biotechnology Account Relationship Matchups

High Positive Relationship

Other Current Liab
+ 1.0
Total Assets
Total Current Liabilities
+ 1.0
Total Assets
Total Stockholder Equity
+ 1.0
Total Assets
Property Plant And Equipment Net
+ 1.0
Total Assets
Accounts Payable
+ 1.0
Total Assets
Cash
+ 1.0
Total Assets

High Negative Relationship

Short Term Debt
- 1.0
Retained Earnings
Short Long Term Debt Total
- 1.0
Retained Earnings
Common Stock
- 1.0
Retained Earnings
Total Current Assets
- 1.0
Retained Earnings
Total Liab
- 1.0
Retained Earnings
Other Stockholder Equity
- 1.0
Retained Earnings

PDS Biotechnology fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets30.9M67.2M77.0M59.4M45.4B47.6B
Other Current Liab1.7M2.2M8.3M2.4M2.8B3.0B
Total Current Liabilities3.3M3.8M9.8M13.6M17.1B17.9B
Total Stockholder Equity27.1M63.2M44.0M26.1M19.0B20.0B
Property Plant And Equipment Net553.1K357.7K527.5K335.0K304.2M319.4M
Net Debt(28.2M)(64.8M)(50.3M)(32.7M)(29.1B)(27.6B)
Retained Earnings(43.8M)(60.7M)(101.6M)(144.5M)(182.1B)(173.0B)
Accounts Payable1.4M1.3M1.2M7.0M1.7B1.8B
Cash28.8M65.2M73.8M56.6M41.7B43.8B
Non Current Assets Total553.1K357.7K527.5K335.0K304.2M319.4M
Cash And Short Term Investments28.8M65.2M73.8M56.6M41.7B43.8B
Common Stock Total Equity10.6K1.7K7.3K10.0K11.4K7.5K
Common Stock Shares Outstanding16.7M25.6M28.6M31.0M36.5M38.3M
Liabilities And Stockholders Equity30.9M67.2M77.0M59.4M45.4B47.6B
Non Current Liabilities Total490.4K231.4K23.2M19.6M9.3B9.7B
Other Current Assets1.5M1.6M2.7M2.5M3.4B3.5B
Other Stockholder Equity70.9M123.9M145.6M170.6M201.1B211.2B
Total Liab3.8M4.0M33.0M33.3M26.4B27.7B
Property Plant And Equipment Gross553.1K357.7K527.5K467.8K421.0K400.0K
Total Current Assets30.3M66.8M76.5M59.1M45.1B47.3B
Common Stock7.3K9.4K10.0K10.9K12.5M13.2M
Capital Surpluse222.6M40.6M70.9M145.6M131.0M122.2M
Property Plant Equipment21.1K553.1K357.7K527.5K474.8K438.1K
Net Tangible Assets11.7M27.1M63.2M44.0M50.6M53.1M
Net Invested Capital27.1M63.2M67.0M49.8M57.3M52.1M
Net Working Capital27.1M63.1M66.7M45.4M52.2M50.2M
Capital Stock7.3K9.4K10.0K10.9K12.6K9.2K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
ZLABZai Lab
ASLEAerSale Corp
ATSAT S Austria
When determining whether PDS Biotechnology Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PDS Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pds Biotechnology Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pds Biotechnology Corp Stock:
How To Invest In PDS
Details
Is PDS Stock a good investment?
Details
What is PDS Biotechnology's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PDS Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PDS Biotechnology. If investors know PDS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PDS Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.03)
Return On Assets
(0.45)
Return On Equity
(1.74)
The market value of PDS Biotechnology Corp is measured differently than its book value, which is the value of PDS that is recorded on the company's balance sheet. Investors also form their own opinion of PDS Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is PDS Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PDS Biotechnology's market value can be influenced by many factors that don't directly affect PDS Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between PDS Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if PDS Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PDS Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY
News Freq…Investor S…100%